These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 3037889)

  • 41. A double-blind evaluation of captopril in elderly hypertensives.
    Cox JP; Duggan J; O'Boyle CA; Mee F; Walsh JB; Coakley D; O'Brien E; O'Malley K
    J Hypertens; 1989 Apr; 7(4):299-303. PubMed ID: 2656860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 43. [Captopril and enalapril in the treatment of renal hypertension].
    Hasanagić H; Djukanović Lj; Subotić Z; Nesić V; Cavrić G
    Srp Arh Celok Lek; 1990; 118(7-8):285-90. PubMed ID: 2097777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observations with captopril (Tensiomin) treatment in hypertensive patients (one-year period).
    Bányai T; Gyimesi A; Pocsay G; Iványi J
    Ther Hung; 1989; 37(3):144-50. PubMed ID: 2686089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicenter trial of low dose captopril administered twice daily in patients with essential hypertension unresponsive to beta blocker-diuretic treatment.
    Muiesan G; Alicandri C; Agabiti-Rosei E; Buoninconti R; Cagli V; Carotti A; Corea L; Dal Palù C; Innocenti PF; Paciaroni E
    J Clin Hypertens; 1987 Jun; 3(2):144-52. PubMed ID: 2886560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New blood pressure lowering drugs in childhood].
    Rascher W
    Monatsschr Kinderheilkd; 1987 Mar; 135(3):122-7. PubMed ID: 3035365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The value of lysinopril in cardiac insufficiency].
    Lambert M; Luccioni R
    Rev Prat; 1990 Oct; 40(23 Suppl):53-8. PubMed ID: 2176346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparisons of long-term effects between converting enzyme inhibitors and conventional therapy in treating mild to moderate hypertension.
    Lin M; Chiang HT; Chen CY
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Nov; 48(5):339-50. PubMed ID: 1659934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ACE inhibitors in the diagnosis and therapy of various forms of hypertension].
    Greminger P; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1988 Apr; 118(14):495-501. PubMed ID: 2897714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of nifedipine in hypertension not controlled by converting enzyme inhibitor and diuretic.
    Mimran A; Ribstein J
    Postgrad Med J; 1986; 62 Suppl 1():135-8. PubMed ID: 3022271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ACE-inhibitors and quality of life.
    Herlitz H
    Scand J Prim Health Care Suppl; 1990; 1():85-8. PubMed ID: 2100371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Captopril in mild and moderate hypertension resistant to diuretics: predictive value of the efficacy by captopril acute test].
    Franco RJ; Curi PR; Kohlmann Júnior O; Ribeiro AB
    Arq Bras Cardiol; 1992 May; 58(5):403-8. PubMed ID: 1340717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical pharmacology of a single doses of captopril and enalapril. Controlled study in subjects with essential hypertension].
    Puccetti F; Franchi M; Landini F; Burresi A; Di Perri T
    Recenti Prog Med; 1987 Apr; 78(4):171-7. PubMed ID: 2820001
    [No Abstract]   [Full Text] [Related]  

  • 55. Enalapril: benefit-to-risk ratio in hypertensive patients.
    Gomez HJ; Cirillo VJ; Smith SG
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S26-9. PubMed ID: 1691415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
    Packer M; Kessler PD; Gottlieb SS
    Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients.
    Bain SC; Le Guen CA; Lunec J; Barnett AH
    J Hum Hypertens; 1991 Dec; 5(6):511-5. PubMed ID: 1791611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.
    Brouwer RM; Bolli P; Erné P; Conen D; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S88-91. PubMed ID: 2580183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Captopril in the treatment of moderate to severe hypertension.
    Kaul UA; Chutani SK; Verma IC; Khalilullah M
    J Assoc Physicians India; 1989 Feb; 37(2):152-4. PubMed ID: 2681137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enalapril worldwide experience.
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Am J Med; 1984 Aug; 77(2A):23-35. PubMed ID: 6089556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.